Share on LinkedInShare on LinkedIn

ARTICLE · 29 APRIL 2021

Endeavour Vision Returns To Guernsey For Second Fund Launch

Guernsey's appeal as a jurisdiction for funds is strengthened by the news that leading venture capital and growth equity firm Endeavour Vision has returned to the island for its second dedicated medtech and...

GuernseyFinance and Banking

Guernsey's appeal as a jurisdiction for funds is strengthened by the news that leading venture capital and growth equity firm Endeavour Vision has returned to the island for its second dedicated medtech and digital health fund.

Carey Olsen's investment funds team in Guernsey advised Endeavour Vision on the successful launch and final close of Endeavour Medtech Growth II (EMG II) LP, with commitments of US$375 million.

The EMG II LP fund will continue the strategy of its US$250 million predecessor (Endeavour Medtech Growth LP) by investing in high-potential European and US companies delivering transformative healthcare technologies to improve the standard of care for patients and bring efficiencies to healthcare systems. In particular, the fund will focus on growth stage companies that have overcome clinical and regulatory hurdles and are starting to generate commercial traction.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from